Ocular Therapeutix
OCUL
OCUL
73 hedge funds and large institutions have $149M invested in Ocular Therapeutix in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1% more capital invested
Capital invested by funds: $147M → $149M (+$1.93M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2.45% less ownership
Funds ownership: 58.55% → 56.1% (-2.4%)
Holders
73
Holding in Top 10
3
Calls
$1.41M
Puts
$787K
Top Buyers
| 1 | +$3.46M | |
| 2 | +$2.25M | |
| 3 | +$1.1M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$1.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$635K |
Top Sellers
| 1 | -$6.46M | |
| 2 | -$3.59M | |
| 3 | -$2.14M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$274K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$226K |